Subsequent studies demonstrated that GluIIβ loss suppresses tumor growth and metastasis by inhibiting receptor tyrosine kinase signaling [23] and modulates cell adhesion molecule (CAM) expression and anti-tumor immune pathways [135]. The gene discussed is NTRK1; the disease is neoplasm.